| Citation: | PAN Lu-yun, LV Tang-feng. Palbociclib Monotherapy for Recurrent or Refractory Advanced Thymic Epithelial Tumors: Review of KCSG LU17-21 StudyJ. Journal of Evidence-Based Medicine, 2025, 25(5): 267-271. DOI: 10.12019/j.issn.1671-5144.202508008 |
No content published by the Journal of Evidence-Based Medicine may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journal without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Journal of Evidence-Based Medicine’ Sponsors or the Editorial Board, unless this is clearly specified.